Results
|
|
4901.
|
|
|
|
4902.
|
|
|
|
4903.
|
Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer. [electronic resource] by
- Okamoto, Isamu
- Miyazaki, Masaki
- Morinaga, Ryotaro
- Kaneda, Hiroyasu
- Ueda, Shinya
- Hasegawa, Yoshikazu
- Satoh, Taroh
- Kawada, Akira
- Fukuoka, Masahiro
- Fukino, Koichi
- Tanigawa, Takahiko
- Nakagawa, Kazuhiko
Producer: 20110203
In:
Investigational new drugs vol. 28
Availability: No items available.
|
|
|
4904.
|
Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma. [electronic resource] by
- Cowey, C Lance
- Amin, Chirag
- Pruthi, Raj S
- Wallen, Eric M
- Nielsen, Matthew E
- Grigson, Gayle
- Watkins, Cathy
- Nance, Keith V
- Crane, Jeffrey
- Jalkut, Mark
- Moore, Dominic T
- Kim, William Y
- Godley, Paul A
- Whang, Young E
- Fielding, Julia R
- Rathmell, W Kimryn
Producer: 20100504
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 28
Availability: No items available.
|
|
|
4905.
|
Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib. [electronic resource] by
- Pinter, M
- Sieghart, W
- Hucke, F
- Graziadei, I
- Vogel, W
- Maieron, A
- Königsberg, R
- Weissmann, A
- Kornek, G
- Matejka, J
- Stauber, R
- Buder, R
- Grünberger, B
- Schöniger-Hekele, M
- Müller, C
- Peck-Radosavljevic, M
Producer: 20120315
In:
Alimentary pharmacology & therapeutics vol. 34
Availability: No items available.
|
|
|
4906.
|
Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells. [electronic resource] by
- Bareford, M Danielle
- Hamed, Hossein A
- Tang, Yong
- Cruickshanks, Nichola
- Burow, Matthew E
- Fisher, Paul B
- Moran, Richard G
- Nephew, Kenneth P
- Grant, Steven
- Dent, Paul
Producer: 20120330
In:
Autophagy vol. 7
Availability: No items available.
|
|
|
4907.
|
|
|
|
4908.
|
|
|
|
4909.
|
|
|
|
4910.
|
|
|
|
4911.
|
|
|
|
4912.
|
Variability of sorafenib toxicity and exposure over time: a pharmacokinetic/pharmacodynamic analysis. [electronic resource] by
- Boudou-Rouquette, Pascaline
- Ropert, Stanislas
- Mir, Olivier
- Coriat, Romain
- Billemont, Bertrand
- Tod, Michel
- Cabanes, Laure
- Franck, Nathalie
- Blanchet, Benoit
- Goldwasser, François
Producer: 20130211
In:
The oncologist vol. 17
Availability: No items available.
|
|
|
4913.
|
|
|
|
4914.
|
|
|
|
4915.
|
Sorafenib prevents escape from host immunity in liver cirrhosis patients with advanced hepatocellular carcinoma. [electronic resource] by
- Nagai, Hidenari
- Mukozu, Takanori
- Matsui, Daigo
- Kanekawa, Takenori
- Kanayama, Masahiro
- Wakui, Noritaka
- Momiyama, Kouichi
- Shinohara, Mie
- Iida, Kazunari
- Ishii, Koji
- Igarashi, Yoshinori
- Sumino, Yasukiyo
Producer: 20120907
In:
Clinical & developmental immunology vol. 2012
Availability: No items available.
|
|
|
4916.
|
|
|
|
4917.
|
|
|
|
4918.
|
|
|
|
4919.
|
Vorinostat and sorafenib increase CD95 activation in gastrointestinal tumor cells through a Ca(2+)-de novo ceramide-PP2A-reactive oxygen species-dependent signaling pathway. [electronic resource] by
- Park, Margaret A
- Mitchell, Clint
- Zhang, Guo
- Yacoub, Adly
- Allegood, Jeremy
- Häussinger, Dieter
- Reinehr, Roland
- Larner, Andrew
- Spiegel, Sarah
- Fisher, Paul B
- Voelkel-Johnson, Christina
- Ogretmen, Besim
- Grant, Steven
- Dent, Paul
Producer: 20100913
In:
Cancer research vol. 70
Availability: No items available.
|
|
|
4920.
|
|